Tsingke, a company specializing in biotechnology innovation, has been honored with the "Top 5 to Watch" award at the Hong Kong International Biotechnology Convention. Selected as one of the "Top 5 Winners" from among more than 50 innovative companies worldwide, this recognition underscores the significant growth potential and value of Tsingke's unique "gene factory service model" in the global biotechnology sector.
Tsingke Shined at BIOHK2023, Garnering Prestigious 'Top 5 to Watch' Award"
Top 5 to Watch
A panel of judges, comprising leaders from Hong Kong's biotechnology industry associations, investors, and industry elites, including founders of renowned investment firms with decades of experience in academic research, product commercialization, project operation, and risk assessment and control in the bio-pharmaceutical industry, conducted thorough discussions and rigorous evaluations of all entries. The "Top 5 to Watch" award winners were determined after meticulous deliberation and assessment of all participating companies.
Tsingke is the originator and executor of the "gene factory" concept. It has established an autonomous industry chain platform by constructing the production platform for raw materials and equipment of gene synthesis elements, the technology platform for intelligent molecular disassembly and assembly of genes, and the propulsion system of the intelligent AI algorithm platform (TSINGKE HELIXTECH). This platform realizes stable, high-efficiency, self-developed, automated, and intelligent gene synthesis production, which can offer customers gene synthesis, modification synthesis, antibody protein production, gene regulation, gene detection, chemical reagents, molecular reagents, instrumentation, and a variety of technical services.
Tsingke Gene Factory: Shaping the Future of Genetic Synthesis with Autonomous Industry Chains
